Feng Jiang-min
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Parathyroid Disorders and Treatments
- Chronic Kidney Disease and Diabetes
-
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Nephrotoxicity and Medicinal Plants 10
-
- Renal and related cancers 2
- Co-authors
- Jianfei Ma (11 shared papers)Lining Wang (15 shared papers)Li Sun (6 shared papers)Li Yao (3 shared papers)Hong Shi (1 shared paper)Danan Wang (3 shared papers)Dong Sun (3 shared papers)Tao Jin (3 shared papers)
- Journals
- American Journal of Nephrology (3 papers)Kidney & Blood Pressure Research (2 papers)Journal of Nephrology (1 paper)Biotechnology Letters (1 paper)Clinical Nephrology (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Feng Jiang-min
24 papers receiving 361 citations
Peers
Comparison fields: 5 of 71
- Nephrology 111
- Pharmacology 40
- Clinical Biochemistry 31
- Genetics 42
- Radiology, Nuclear Medicine and Imaging 53
Countries citing papers authored by Feng Jiang-min
This map shows the geographic impact of Feng Jiang-min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Jiang-min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Jiang-min more than expected).
Fields of papers citing papers by Feng Jiang-min
This network shows the impact of papers produced by Feng Jiang-min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Jiang-min. The network helps show where Feng Jiang-min may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Jiang-min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 56 | |
| 2 | 2006 | 53 | |
| 3 | 2015 | 52 | |
| 4 | 2013 | 31 | |
| 5 | 2010 | 28 | |
| 6 | 2016 | 26 | |
| 7 | 2011 | 20 | |
| 8 | 2014 | 11 | |
| 9 | 2012 | 11 | |
| 10 | 2014 | 10 | |
| 11 | 2012 | 10 | |
| 12 | 2010 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2017 | 6 | |
| 15 | Roles of mycobacterium tuberculosis ESAT-6 in the development of renal injury. | 2015 | 6 |
| 16 | 2017 | 5 | |
| 17 | Effects of prostaglandin E1 on the progression of aristolochic acid nephropathy. | 2005 | 5 |
| 18 | [Influence of hypoxia caused by impairment of peritubular capillary on the progression of chronic aristolochic acid nephropathy]. | 2006 | 5 |
| 19 | 2012 | 4 | |
| 20 | 2012 | 4 |
About Feng Jiang-min
Feng Jiang-min is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Nephrology, Surgery and Pharmacology, having authored 24 papers that have together received 366 indexed citations. Recurring topics across this work include Nephrotoxicity and Medicinal Plants (10 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Traditional Chinese Medicine Analysis (3 papers), Mesenchymal stem cell research (2 papers), Renal and related cancers (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Tuberculosis Research and Epidemiology (2 papers) and Acute Kidney Injury Research (2 papers). The work is most often cited by research in Nephrology (111 citations), Pharmacology (40 citations), Clinical Biochemistry (31 citations), Genetics (42 citations) and Radiology, Nuclear Medicine and Imaging (53 citations). Feng Jiang-min has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Jianfei Ma, Lining Wang, Li Sun, Li Yao, Hong Shi, Danan Wang, Dong Sun, Tao Jin, Changlong Lu and Yao Li. Their work appears in journals such as American Journal of Nephrology, Kidney & Blood Pressure Research, Journal of Nephrology, Biotechnology Letters and Clinical Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.